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Abstract
Background: For high-risk individuals and their healthcare providers, finding the right balance between
promoting physical activity and minimizing the risk of adverse events can be difficult. More information on the
prevalence and influence of adverse events is needed to improve providers' ability to prescribe effective and safe
exercise programs for their patients.
Methods: This study describes the type and severity of adverse events reported by participants with
cardiovascular disease or at-risk for cardiovascular disease that occurred during an unsupervised, home-based
walking study. This multi-site, randomized controlled trial tested the feasibility of a diet and lifestyle activity
intervention over 1.5 years. At month 13, 274 eligible participants (male veterans) were recruited who were
ambulatory, BMI > 28, and reporting one or more cardiovascular disease risk factors. All participants attended
five, face-to-face dietitian-delivered counseling sessions during the six-month intervention. Participants were
randomized to three study arms: 1) time-based walking goals, 2) simple pedometer-based walking goals, and 3)
enhanced pedometer-based walking goals with Internet-mediated feedback. Two physicians verified adverse event
symptom coding.
Results: Enrolled participants had an average of five medical comorbidities. During 1110 person months of
observation, 87 of 274 participants reported 121 adverse events. One serious study-related adverse event (atrial
fibrillation) was reported; the individual resumed study participation within three days. Non-serious, study related
adverse events made up 12% of all symptoms – predominantly minor musculoskeletal events. Serious, non-study
related adverse events represented 32% of all symptoms while non-serious, non-study related adverse events
made up 56% of symptoms. Cardiovascular disease events represented over half of the non-study related adverse
event symptoms followed by musculoskeletal complaints. Adverse events caused 50 temporary suspensions
averaging 26 days in duration before physician medical clearance was obtained to resume walking.
Conclusion: Men at high risk for adverse cardiovascular events can safely be advised to start a progressive
walking program. Results suggest that minor to serious medical problems unrelated to exercise are a major
barrier to walking adherence. Helping individuals with chronic illness return to physical activity quickly but safely
after an adverse event is an important component of any physical activity intervention targeting this population.
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Exercise, particularly vigorous exercise, increases the risk
of adverse cardiovascular events acutely but over the long
term, individuals who exercise regularly are at lower risk
for these events than those who remain sedentary [1-5].
The risk of an adverse cardiovascular event occurring dur-
ing or following an acute bout of physical activity (PA) is
greatest among new exercisers who are formerly seden-
tary, middle- to older-aged, and/or who display certain
disease risk factors [1,6]. Although there is an elevated risk
for serious adverse events (AE's) such as acute myocardial
infarctions or sudden cardiac death among sedentary indi-
viduals starting a vigorous PA program, this risk is attenu-
ated over time with regular PA participation and increased
levels of fitness [1,2,7-10]. Individuals with multiple car-
diac risk factors live longer if they are physically active [5].
For high-risk individuals and their healthcare providers,
finding the right balance between promoting PA and min-
imizing the risk of adverse cardiovascular events can be
difficult. Exercise in a supervised and monitored setting
such as a formal cardiovascular rehabilitation program is
often recommended for those at highest risk as in the case
of those who have recently had a heart attack or those with
congestive heart failure [11-14]. However, many high-risk
individuals do not qualify for cardiovascular rehabilita-
tion programs or do not have access to or insurance cov-
erage for such programs [15,16].
Cardiovascular risk is not the only risk associated with
starting an exercise program. Minor musculoskeletal inju-
ries including sprains, strains, joint pain, and overuse
injuries are common among sedentary people who try to
start an exercise program [17]. Musculoskeletal risk is
likely to be higher for people who are particularly unfit or
obese who are starting a PA program. Additionally, there
are medication-related problems for individuals with
multiple comorbidities [18]. Individuals with diabetes
may experience low blood sugar after an episode of PA,
and individuals taking multiple blood pressure medica-
tions may need to decrease their blood pressure medica-
tions to avoid low blood pressure as they become more
active. For many high-risk individuals, concerns or uncer-
tainty about the safety of engaging in PA are valid exercise
barriers and may be, in part, attributed to sensational
media accounts of cardiac events occurring after vigorous
PA participation [1,19]. Similarly, despite the growing evi-
dence of the safety of mild to moderate PA for high-risk
populations, some physicians are reluctant to prescribe
PA due to the legal concerns of a patient experiencing a
serious medical event [15,20]. One approach to reduce
the occurrence of minor and severe exercise-related medi-
cal events is the prescription of progressive exercise pro-
grams emphasizing mild to moderate intensity physical
activities like walking that can be easily integrated into a
person's lifestyle.
A home-based walking program may be a safe and effec-
tive way for high-risk individuals to increase their PA
[11,21]. Walking is a moderate-intensity form of PA that
carries less risk for adverse cardiovascular or musculoskel-
etal events than more vigorous forms of PA. However, we
know very little about the risks involved with such unsu-
pervised lifestyle activity programs [20,22]. Many PA
intervention studies explicitly exclude high-risk individu-
als. Those studies that included high-risk individuals
rarely provide detailed information about adverse events
that occurred during the course of the intervention, partic-
ularly for community-based studies featuring lifestyle
activity interventions [20]. If the public health goal for
exercise prescription is to promote long-term PA partici-
pation in high-risk groups, healthcare providers not only
need an evidence-base that documents the influence of
cardiovascular events and musculoskeletal injuries to
improve program prescription,[20] but also evidence of
the impact of non-intervention-related morbidity and
transient illness on exercise adherence.
In this manuscript, we present adverse event (AE) data
from a multi-center randomized controlled trial (RCT) of
a lifestyle modification program for male veterans with
cardiac risk factors. We present a detailed analysis of seri-
ous intervention-related adverse events, non-serious inter-
vention-related events, and both serious and non-serious
events unrelated to the intervention. This information
may be useful to the medical care provider prescribing a
home-based walking program for high-risk patients as
well as for researchers or program developers who are
designing safe, home-based walking programs for these
individuals. Additionally, to enhance future PA research
that involves unsupervised PA interventions or samples
with high levels of disease morbidity, we provide a
detailed description of the intervention protocols used to
insure participant safety and monitoring of AE's.
Methods
Research design
This study is a descriptive analysis of the adverse events in
Veterans Walk for Health, a multi-site RCT with three
intervention arms. Participants were randomized to one
of three study groups: (1) five-session nutritional coun-
seling program with time-based walking goals (i.e., con-
trol); (2) five-session nutritional counseling program +
simple pedometer feedback; and (3) five-session nutri-
tional counseling program + enhanced pedometer (web-
based) feedback. All participants were followed for six
months.
Study population
Individuals with cardiovascular (CVD) risk factors or
known CVD were recruited from six Department of Veter-
ans Affairs (VA) medical centers located across the UnitedPage 2 of 12
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were either referred by a VA physician for outpatient nutri-
tional counseling or who responded to advertisements for
the study posted at each site. Individuals were eligible if
they had a body mass index (BMI) = 28, were ambulatory
as demonstrated by the ability to comfortably walk for at
least one block, and reported at least one major risk factor
for CVD including diabetes, coronary artery disease,
hypercholesterolemia, hypertension, or obesity. Partici-
pants identified a VA physician who could give medical
clearance for study participation; no cardiovascular
screening tests were conducted as part of the inclusion cri-
teria. Eligible individuals were required to be able to com-
municate clearly in English and to be sedentary. Sedentary
was defined as self-report of performing less than 30 min-
utes per day of moderate intensity PA on five or more days
per week. Eligible participants also needed to express will-
ingness to try a walking program. Finally, participants
were excluded if they reported using a pedometer during
the 28 days prior to enrollment.
Intervention
Each participant met with a dietitian over a six-month
period for five face-to-face counseling sessions on diet and
PA. All participants received behavioral counseling on die-
tary change using an adaptation of the Medical Nutrition
Therapy Protocol for Weight Management (MNT proto-
col) published by the American Dietetics Association [23].
The intervention protocol for this study was intended to
encourage the combination of calorie reduction and walk-
ing for weight loss. Participants in the control group
received standard dietary counseling and were encouraged
to set short, time-based walking goals for exercise. Daily
walking time was recorded in a log that was reviewed at
each counseling session, and new time-based walking
goals were set. Individuals in the simple pedometer group
received the MNT protocol and also were taught to self-
monitor and track their daily walking levels using a Yamax
Digiwalker 200 pedometer. At each counseling session,
the dietitian and participant reviewed logged step-count
data and revised short- and long-term walking goals with
the aim of progressively increasing daily walking. In the
enhanced pedometer group, participants' MNT coun-
seling was paired with an "enhanced" SportBrain pedom-
eter. The SportBrain pedometer not only permitted
participants to obtain conventional step-count feedback
but also allowed the weekly upload of time-stamped ped-
ometer data to a website. The website then generated per-
sonalized and graphical analysis (by time of day) of
progress towards attainment of daily walking goals.
Safety protocols
Safety protocols were implemented to minimize the risk
for AE's occurring in response to the walking program.
Study protocols and forms for the research staff and par-
ticipants can be found on the study website [24]. First, all
participants were required to obtain medical clearance
from a VA physician prior to the start of PA counseling
(session 2) using a standardized form provided by the
research staff after an orientation session explaining the
study objectives [see Additional file 1]. Unlike some PA
trials that often exclude chronically diseased individuals,
Veterans Walk for Health specifically sought out at-risk
individuals whose risks were already being managed
through regular physician contact. This step assured that
the participant was under medical supervision and that
his physician viewed walking as a safe and beneficial activ-
ity given the participant's medical history and present
health status. Additionally, the medical clearance form
[see Additional file 1] provided physicians with the
option to: 1) endorse study participation; 2) deny partici-
pation due to known risks; 3) postpone clearance contin-
gent on further medical assessment; 4) or acknowledge
that they lacked adequate knowledge of the patient's med-
ical history to make an informed decision on participa-
tion. Participants were not permitted to start the walking
intervention until written medical clearance was
obtained. Second, each participant was counselled to
slowly and realistically increase the speed and duration of
their walking program goals to reduce the risk of muscu-
loskeletal injury and adverse CVD events. Dietitians also
reviewed a walking handout, which gave instructions on
warming up, stretching, and exercise progression. Third,
participants with diabetes were provided with a handout
on exercising safely with diabetes, developed by the Amer-
ican Academy of Family Physicians and the American Dia-
betes Association. Finally, if a participant reported either
a serious AE or a concerning contraindication to the walk-
ing program, the participant was suspended from the
study until written medical clearance was provided by the
participant's physician again to resume study participa-
tion [see Additional file 2]. To minimize study attrition,
the study coordinator at the participant's site assisted sus-
pended participants in obtaining medical clearance.
This study was approved by the Investigational Review
Boards at each of the six participating VA medical centers
in Memphis, Tennessee; Miami, Florida; Oklahoma City,
Oklahoma; San Diego, California; Tucson, Arizona; and
Topeka, Kansas as well as the coordinating VA medical
center in Ann Arbor, Michigan. All eligible participants
signed written informed consent documents prior to
enrollment.
Monitoring and classification of adverse events
Due to the high risk for adverse CVD events such as heart
attacks and stroke among participants, all members of the
research team were charged with the responsibility to pro-
tect study participants. Any research staff person who had
any reason for concern about the safety of a participant,Page 3 of 12
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immediately to either the site principal investigator or to
the study principal investigator. Every dietitian and site
coordinator in the study had the authority to suspend par-
ticipation until medical clearance was re-obtained. Site
coordinators and dietitians were responsible for notifying
the Ann Arbor coordinator of all AE's using a standardized
form and checklist to assure compliance with Internal
Review Board (IRB) safety protocols [see Additional file
3]. AE reports were transmitted to the coordinating site by
fax or PDF electronic file, insuring that all participant data
was kept confidential by assigning numerical codes to par-
ticipant and site. All AE reports were reviewed by the
study's principal investigator; a physician who confirmed
AE coding. The Ann Arbor study coordinator maintained
a master log of all study-related AE's. The AE report form
also provided research coordinators at each site with a
means to track temporary study suspensions due to AE's
and update the coordinating site regarding the resump-
tion of study participation for suspended individuals.
Coding of adverse events
To insure consistent AE coding, all AE report forms were
analyzed and coded by two physicians at the central site
according to the type(s) and severity of adverse medical
symptoms. Coding discrepancies were discussed and
resolved. Symptoms were classified as either possibly
study-related or probably not study-related. Adverse cardi-
ovascular events or symptoms that occurred during or
immediately following a walk or in the six hours follow-
ing an episode of walking were considered study related.
In some cases, investigators used professional judgement
to code study-related symptoms (e.g., rash from an accel-
erometer belt or delayed post-walking musculoskeletal
soreness) and unrelated events (e.g., previously scheduled
knee joint replacement or ACL surgery). Second, individ-
ual symptoms were summarized according to categories
describing the general nature of the AE (e.g., cardiovascu-
lar, musculoskeletal, motor vehicle accident). When
appropriate, subcategories were developed to more pre-
cisely describe specific symptoms or conditions with a
high prevalence (e.g., uncontrolled blood pressure,
angina, etc. for CVD adverse events).
Symptoms were then rated according to medical severity
using a dichotomous rating of serious or non-serious clini-
cal severity (Table 1). Serious AE symptoms were defined
as symptoms that posed a threat to the health of the par-
ticipant and which mandated study suspension for imme-
diate medical treatment or consultation with a physician
as consistent with most IRB guidelines. Non-serious
events were categorized as meaningful events of moderate
or minor clinical severity. For the Results section, AE's
were analyzed and summarized according to four catego-
ries: 1) serious study-related events, 2) non-serious study
related events 3) serious non-study related events, and 4)
non-serious non study related events.
Data analysis
Basic descriptive statistics were used to summarize the
findings. Means and standard deviations were calculated
for age, BMI, and number of presenting health conditions.
Frequency counts and percentages were used to describe
baseline demographic characteristics and health condi-
tions as well as the type and severity of AE's reported dur-
ing the course of the study.
Results
Participants
Between study inception on August 29, 2005 and Novem-
ber 27, 2006, 274 individuals had been recruited and
enrolled in the Veterans Walk for Health trial. Of the
enrolled participants, 244 had been randomized to the
three study arms. One of the original six sites stopped
recruiting due to difficulties implementing study proto-
cols; only data from participants recruited and enrolled at
the remaining five sites are analyzed here. At baseline, the
mean age of participants was 56.3 years (SD = 9.9) with a
range between 30 and 84 years. Table 2 provides a brief
summary of participant demographic characteristics. The
sample reported a high level of education with almost
81% of participants attaining at least some college-level
education, and the majority reported an annual income of
less than $40,000.
A total of 387 individuals were physician- or self-referred
to the study. Seventeen individuals could not be reached
by phone for screening. Of the 370 persons who under-
went screening, 49 were excluded for the following rea-
sons: unable to walk a block (n = 13); BMI < 28 (n = 15);
were not sedentary (n = 17); female (n = 2); already using
a pedometer (n = 1); and mental incapacity (n = 1). A total
of 33 individuals were excluded due to lack of interest in
becoming physically active or participating in a walking
program. Another 14 individuals refused to sign the
informed consent form resulting in 274 participants
Table 1: Summary of study and non-study related adverse events symptoms
Severity, n (%) Study Related Non-study Related
Serious 2 (1.4) 46 (31.5)
Non-Serious 17 (11.6) 81 (55.5)Page 4 of 12
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were enrolled dropped out before randomization. Over-
all, 29% of prospective participants were excluded during
recruitment with an additional 8% of eligible participants
failing to return after enrollment. A total of 244 partici-
pants were randomized to the three study arms. Because
AE tracking was initiated upon study enrollment, all
demographic and AE characteristics summarized in this
study describe data for enrolled participants including
those individuals who dropped out of the study between
enrollment and randomization.
Table 3 summarizes the high prevalence of sample disease
morbidity. Participants reported an average of 5.2 health
conditions (SD = 2.3) pertaining to a specific chronic dis-
ease or functional impairment. Almost 74% of the sample
reported four or more health conditions while fewer than
14% cited two or fewer health problems. Baseline body
mass index (BMI) assessments averaged 36.1 (SD = 5.2).
The effect of the high levels of disease and potentially dis-
abling conditions is reflected by the finding that less than
15% of respondents rated their health as very good to excel-
lent.
Adverse events
As of November 27, 2006, 121 AE reports were submitted
for 87 participants (32% of all enrolled study partici-
pants), representing 146 discrete symptoms that are sum-
marized in Tables 4 and 5. Adverse event statistics
summarized in this study reflect 1109.8 cumulative
months of participant exposure to study-related walking
participation. A total of 24 adverse symptoms were filed in
20 reports prior to randomization by 20 enrolled partici-
pants. Table 5 highlights that AE's unrelated to study par-
ticipation constituted 87% (n = 127) of all adverse
symptoms. Approximately 53% of all AE reports were gen-
erated by 11% of the enrolled study participants (n = 29).
Tables 4 and 5 show that CVD symptoms and muscu-
loskeletal conditions represented the most common med-
ical problems experienced by participants over the course
of the study.
Only one serious study-related AE report has been
reported to date. This report was submitted by a single
individual who experienced the two symptoms of dizzi-
ness and shortness of breath following a walk. These
symptoms were subsequently attributed to atrial fibrilla-
tion that resulted in a brief hospitalization for observa-
Table 2: Demographic characteristics of participants
N %
Ethnicity (N = 272)*, **
White/Hispanic 182 66.9
African American 74 27.2
Native American or Alaskan Native 14 5.1
Asian 1 0.4
Pacific Hawaiian or other Pacific Islander 1 0.4
Not given 5 1.8
Education (N = 272) **
Less than High School 10 3.7
High School Graduate 43 15.8
Some College 128 47.1
College Graduate 63 23.2
Graduate School 28 10.3
Income (N = 272) **
< $20,000 89 32.7
$20,000 – $39,999 71 26.1
$40,000 – $59,999 46 16.9
$60,000 – $80,000 31 11.4
> $80,000 26 9.6
Not given 11 4.0
Smoker ** 44 16.9
Mean Body Mass Index (BMI) per participant† 36.1 ± 5.3
* Total frequency exceeds 100% due to three individuals who endorsed two or more ethnicities.
** Missing data for two individuals reduced enrolled sample n to 272 for this descriptive analysis.
† Analysis based on N = 274.Page 5 of 12
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obtaining medical clearance from his physician to resume
study participation.
Approximately 12% of total adverse symptoms (n = 17)
were non-serious study related AE's with minor muscu-
loskeletal complaints constituting most of these events.
Five of the nine musculoskeletal AE's reported related to
bone or connective tissue pain in the foot, heel, or knee
that occurred after walking. The remaining four muscu-
loskeletal events pertained to post-activity muscle cramp-
ing or muscle soreness. Of the four non-serious
cardiovascular symptoms, three involved shortness of
breath after walking and one concerned light-headedness
after a walk. Three non-serious study-related dermatolog-
ical events were recorded including one participant sub-
mitting two separate reports of a rash caused by wearing a
study accelerometer belt and another participant report-
ing walking-induced blisters. Lastly, one minor neurolog-
ical complaint was the occurrence of low back pain
aggravated by a walk. Three participants were suspended
for an average of 12.7 days (SD = 3.2) for non-serious
study related events; one participant who had experienced
a non-serious walking related event withdrew for medical
reasons.
Serious AE's not related to the study comprised 31.5% (n
= 46) of all the reported AE symptoms documented.
Within this category, cardiovascular events represented
50% (n = 23) of reported symptoms with most partici-
pants presenting to the emergency room with two or more
symptoms per incident. Serious cardiovascular incidents
included six reports of angina, four cases of dizziness or
light-headedness, and three cases reported for each of the
symptoms of orthopnea, shortness of breath, and serious
hypertension (i.e., systolic pressure > 160 or diastolic
pressure > 95). Additionally there were two reports of
both strokes and diaphoresis. One of the participants who
had a stroke subsequently died.
The remaining twenty-three serious AE's not related to
study participation reflected a wide range of medical
events. Metabolic abnormalities were the most common
problem including six cases of hypoglycemia, hypokale-
mia, or sudden weight gain. Four participants were hospi-
talized for severe depressive symptoms, four participants
Table 3: Participant baseline health characteristics at baseline assessment
Frequency %
Health Status (N = 272)*
Very Good to Excellent 39 14.2
Good 111 40.5
Poor to Fair 99 40.9
Not given 10 4.4
Baseline Comorbidities (N = 272)*
Hypertension 192 70.6
High Cholesterol 178 65.4
Depression, anxiety, or other mood disorder 159 58.5
Osteoarthritis 142 52.2
Diabetes 121 44.5
Sleep disorders 118 43.4
Chronic pain 117 43.0
Hearing problems 95 34.9
Angina 63 23.2
Lung disease, emphysema, asthma, or 
bronchitis
58 21.3
Heart Attack 34 12.5
Cataracts 34 12.5
Cancer (non-skin) 24 8.8
Congestive Heart Failure 22 8.1
Stroke 18 6.6
Hip or knee joint replacement surgery 18 6.6
Glaucoma 14 5.1
Osteoporosis 14 5.1
Parkinson's disease 1 0.4
Mean Number of Comorbidities per 
participant *
5.2 ± 2.3
* Missing data for two individuals reduced enrolled sample n to 272 for this descriptive analysis.Page 6 of 12
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Table 4: Clinical typology of adverse events symptoms
Type of Medical Event Number of Adverse Events
Cardiovascular
High/Low blood pressure 32
Angina/Chest tightness 9
Orthopnea, low extremity edema 7
Shortness of breath 9
Light-headedness, dizziness 12
Diaphoresis 2
Stroke, myocardial infarction 2
Other CVD 1
74
Metabolic/Endocrine
Sudden weight gain 3
Hypo-, Hyperglycemia 5
Hypo-, Hyperkalemia 2
10
Neuro-Psychological
Neuro-motor 4
Mood Disorder 4
8
Musculoskeletal
Laceration, scrape, bruises 3
Muscle pulls, strains, sprains, soreness 13
Bone or joint trauma/fracture 11
27
Gastrointestinal
Gastric reflux 1
Rectal bleeding 2
3
Infectious Disease
Dermatological (fungus, blister, boil) 4
Viral, bacterial, fungal, or insect 11
15
Medical Events 137
Motor Vehicle Accident 3
Surgical Comorbidity 6
Total Number of discrete symptoms 146
Note. These symptoms represent 121 individual adverse event reports from 87 separate individuals. Thus, multiple symptoms could be reported on 
an individual report and some participants experienced 2 (n = 24) or 3 (n = 5) adverse events during the trial period summarized for this study.
International Journal of Behavioral Nutrition and Physical Activity 2007, 4:20 http://www.ijbnpa.org/content/4/1/20were hospitalized for bacterial or viral infections, and four
participants underwent surgical procedures: one carotid
artery occlusion, one liver transplant, one ACL repair for a
pre-existing condition, and one knee joint replacement
for a pre-existing condition. Three serious musculoskele-
tal reports included accidental trauma to a finger, motor
vehicle accident-related back pain, and electric burns.
Finally, two participants reported moderate psychological
and musculoskeletal trauma from motor vehicle accidents
resulting in temporary suspension. A total of 15 partici-
pants were temporarily suspended for serious AE's not
related to the study for average suspension duration of
28.3 days (SD = 42.0) before obtaining physician permis-
sion to resume walking. Seventeen participants who expe-
rienced serious AE's unrelated to walking withdrew from
the study.
Non-serious AE's not related to study participation
included events of minor to moderate severity that repre-
sented 56% of all adverse symptoms. Cardiovascular
symptoms made up 45 of the 81 non-serious symptoms
in this category. These CVD symptoms can be summa-
rized as: 29 reports of poorly regulated blood pressure, 6
cases of dizziness or light-headedness, 3 complaints of
angina, 2 cases of shortness of breath, 2 cases of orthop-
nea, 2 cases of peripheral edema, and 1 report of abnor-
mal cardiac stress test results.
In addition to non-serious CVD events unrelated to the
study, a diverse number of non-cardiac medical events
were reported. Fifteen non-serious musculoskeletal inju-
ries unrelated to walking were reported including: five
cases of muscle or joint soreness; four minor falls causing
bruising of bones or joints; three significant bruises or lac-
erations; one case of shin splints; one report of a swollen
knee joint; and one ankle sprain. Eight cases of infectious
agents were reported including a skin boil, influenza,
painful reactions to insect stings/bites, and upper respira-
tory tract infections. Metabolic or endocrine events
included three cases of poorly regulated blood sugars and
one case of sudden weight gain. Other minor non-study
related AE's included three cases of neurological events
due to instability caused by vertigo and mild sciatica, two
cases of rectal bleeding, one report of gastric reflux, and
one motor vehicle accident. Two outpatient surgeries for
cataracts and a hernia were also non-serious AE's unre-
lated to the study. Non-serious AE's unrelated to the study
resulted in 31 participants being suspended for an average
of 27.3 days (SD = 33.7) before resuming study participa-
tion, and 9 participants who experienced non-serious AE's
unrelated to walking withdrew from the study.
Discussion
Our study demonstrates that chronically diseased individ-
uals can safely start an unsupervised home-based walking
Table 5: Classification of adverse events by cause and relatedness to study intervention
Study Related Non-study Related
Category, Freq: n (%) Serious Non-Serious Minor-Moderate Serious Non-Serious Minor-Moderate Total
Cardiovascular 2 (1.4) 4 (2.6) 23 (15.8) 45 (30.8) 74 (50.6)
Musculoskeletal 0 (0.0) 9 (6.2) 3 (2.1) 15 (10.3) 27 (18.6)
Metabolic-Endocrine 0 (0.0) 0 (0.0) 6 (4.1) 4 (2.6) 10 (6.7)
Infectious Disease 0 (0.0) 3 (2.1) 4 (2.7) 8 (5.5) 15 (10.3)
Psycho-Neurological 0 (0.0) 1 (0.7) 4 (2.7) 3 (2.1) 8 (5.5)
Gastrointestinal 0 (0.0) 0 (0.0) 0 (0.0) 3 (2.1) 3 (2.1)
Motor Vehicle Accident 0 (0.0) 0 (0.0) 2 (1.4) 1 (0.7) 3 (2.1)
Surgical 0 (0.0) 0 (0.0) 4 (2.7) 2 (1.4) 6 (4.1)
Total 2 (1.4) 17 (11.6) 46 (31.5) 81 (55.5) 146 (100.0)
Note. Serious AE's were defined consistent with most IRB definitions as a 1) death; 2) a life threatening experience; 3) hospitalization or 
prolongation of hospitalization; 4) persistent significant disability or incapacity; or 5) an event that jeopardizes the subject and may require medical 
or surgical treatment to prevent one of the preceding outcomes. Non-serious AE's consisted of both minor and moderately serious AE's. 
Moderately serious AE's were defined as concerning new medical symptoms (not imminently life threatening) or acute events that either required 
suspension until clearance by a physician to rule out potential for Serious AE's (cardiopulmonary dysfunction) and insure optimal patient self-care 
(e.g., medication, blood pressure, or blood sugar regulation) or, events causing voluntary cessation of walking by the participant until the aggravating 
event passed (e.g., illness, serious musculoskeletal injury, motor vehicle accident). Minor AE's were defined as events not necessitating study 
suspension and causing minor discomfort or inconvenience to the participant as a result of study participation (e.g., sore muscles, blisters, 
equipment malfunction).Page 8 of 12
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a high prevalence of chronic disease morbidity in our
sample, only one participant reported a serious case of
atrial fibrillation related to walking. Only thirteen percent
of AE symptoms were study-related and were predomi-
nantly non-serious cardiovascular or musculoskeletal
symptoms of minor clinical severity. In contrast, almost
90% of all AE's were health problems unrelated to the
walking. The majority of non-study related AE's were non-
serious symptoms that were associated with poor manage-
ment of CVD and diabetes symptoms, such as uncon-
trolled hypertension or poorly regulated blood glucose
levels. However, the prevalence of AE's unrelated to the
study that lead to temporary suspensions from walking
underscores the fact that chronically diseased older adults
face a wide variety of medical events that may act as barri-
ers to exercise. These events are quite diverse and can
range from acute illnesses to emergency surgeries and
severe depressive episodes.
The impetus for this paper was to contribute to the forma-
tion of an evidence base that describes the incidence of AE
issues related to community-based, lifestyle activity inter-
ventions for high-risk individuals. A recent review on this
topic by investigators representing the Behavioral Change
Consortium (BCC) of the National Institutes of Health
(NIH) provided preliminary descriptive findings with
which to compare our results [20]. The BCC review
offered similar results to the present study and reported
that no serious study-related AE's occurred in response to
moderate PA interventions delivered in eleven RCT's
involving over 5000 participants. Among three BCC stud-
ies providing detailed AE information, the review found
that 75% to 87% of AE's were unrelated to study partici-
pation and consisted of transient minor or moderate clin-
ical symptoms similar to those reported in Veterans Walk
for Health. Despite differences in sample characteristics
and intervention protocols, these findings collectively
suggest that moderate-intensity PA interventions are safe
but morbidity unrelated to exercise participation is a crit-
ical challenge to sustained PA participation.
Recently published findings from the Lifestyle Interven-
tions and Independence for Elders pilot trial (LIFE-P) [25]
are among the first well-documented AE findings in a
high-risk medical population performing lifestyle activity
and provide a basis of comparison for findings in the
present study. The LIFE-P study was a RCT designed to
pilot study protocols for a trial comparing a moderate-
intensity PA intervention to a health education program
in sedentary adults between the ages of 70 and 89 years.
LIFE-P protocols required close monitoring of AE's for
participants in both the PA intervention and sedentary
control groups. Like Veterans Walk for Health, there was a
high prevalence of disease morbidity among the sample
of 424 participants; however, the average age of LIFE-P
participants was 20 years greater than our sample. LIFE-P
results showed no significant differences in the occurrence
of AE's between the PA intervention group and the health
education control group except for a higher prevalence of
abnormal heart rhythm reports in the active group. In the
younger Veteran's Walk for Health sample, only one seri-
ous study-related event occurred and, like LIFE-P, this
event was related to an abnormal heart rhythm. Collec-
tively, results from both the LIFE-P and Veteran's Walk for
Health studies suggest that a moderate-intensity lifestyle
PA like walking can be safely performed without supervi-
sion and that medical adverse events are a common occur-
rence that must be monitored to ensure at-risk individuals
derive the benefits of sustained PA participation.
Veterans Walk for Health reflects a pragmatic approach to
preventive medicine that views exercise therapy as a fun-
damental component of disease management in primary
care settings. Recent reviews have documented the pro-
spective and RCT evidence in support of exercise as a cost-
effective, adjunct therapy for both the prevention and
management of morbidity and mortality associated with
several chronic diseases, including obesity [11,13,26-31].
The greatest benefit in mortality reduction is evidenced by
those individuals who transition from a sedentary to
moderately active lifestyle, even for those with high BMI
or those who initiate exercise late in life [2,26,32,33].
However, there is growing recognition that public health
efforts to promote increased levels of PA through lifestyle
activities are paradoxically undermined by barriers cre-
ated by national exercise guidelines.
A growing number of medical professionals and PA
researchers have identified the extensive pre-activity
screening process recommended by exercise guidelines as
a significant barrier to exercise initiation in older and at-
risk adults. Exercise guidelines disseminated by medical
organizations like the American Heart Association (AHA)
[21] and the American College of Sports Medicine
(ACSM) [34,35] were designed to identify health condi-
tions that are contra-indications to vigorous PA in order to
minimize the risk for severe cardiovascular events in
response to vigorous intensity exercise. The practical util-
ity of these pre-activity screening procedures has been
questioned as a number of studies have revealed that the
risk of such events is quite low while information
obtained is poor in predicting future severe cardiovascular
AE's in older and chronically ill individuals [1,6,36-38].
Some critics have observed that the economic and logisti-
cal costs associated with conducting these procedures cre-
ates an unnecessary burden on both patients and the
medical system while undermining individuals' exercise
motivation by implying that PA is hazardous [15,16,20].
Given the number of sedentary adults screened out by thisPage 9 of 12
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exceed the risk-protective benefit gained from screening at
a population level [6,15,16,20,38-40]. Rigorous pre-activ-
ity screening also appears unnecessary for those who
desire to start a lifestyle activity program consisting of
mild- to moderate-intensity activities like walking. The
risk for serious cardiovascular-related AE's occurring as a
result of walking is considered similar to performing nor-
mal activities of daily living, [1] yet current screening
guidelines do not provide a practical framework to help
older and chronically diseased individuals overcome the
ubiquitous medical problems unrelated to exercise that
can undermine activity adherence. Recognizing the weak-
nesses in early guidelines, two expert medical panels have
stated that exercise testing is unnecessary for adults that
are asymptomatic for CVD and want to initiate a moder-
ate PA program [39,41] with the caveat that these individ-
uals collaborate with their doctors about their exercise
program.
Veterans Walk for Health employed an AE monitoring sys-
tem that encouraged participants to work with VA physi-
cians to manage medical problems identified during study
participation and to grant medical authorization to
resume study participation when doctors deemed it safe
for an individual to resume walking. The VA medical sys-
tem offers a unique context in which to test innovative
interventions that have broader implications for the
American public. Development of healthy lifestyle pro-
gramming is a priority in the VA medical system where the
prevalence of chronic disease morbidity and functional
disability among veterans is currently above national aver-
ages [42,43]. Continuous improvement of patient care
and safety are core missions of the VA, and treatment of
obesity and obesity-related disorders became a high prior-
ity in 2004. Veterans Walk for Health reflects this initiative
to develop and evaluate safe and sustainable lifestyle
interventions to improve health-related quality of life
among veterans.
The screening and safety approach utilized in Veterans
Walk for Health offers one model with several unique
strengths for promoting PA in a primary care setting.
Reflecting a paradigm shift in exercise prescription from
the snapshot approach using stress testing to predict activ-
ity participation risk, the current study utilized an ongo-
ing monitoring and assessment process between the
participant and the intervention team with backup from
the participant's physician. We feel the medical clearance
forms [see Additional files 1 and 2] provide a pragmatic
means to recruit high-risk populations that do not impose
undue burden on either participants or their physicians
yet give physicians alternatives to assess the cost-benefit
ratio of participant PA participation. The AE checklist [see
Additional file 3] was significantly enhanced during the
first weeks of the trial to improve the accuracy and relia-
bility of AE reporting among sites. To encourage consist-
ency in AE reporting, the form was streamlined to
explicitly differentiate and categorize AE's that merit study
suspension and require medical clearance versus events
where consultation with a primary care provider is advo-
cated or no suspension is needed. Moreover, mandatory
suspensions (as well as voluntary suspensions by the par-
ticipant) are clearly highlighted in a special box to help
site coordinators identify and track the medical status of
suspended participants. Study personnel were also
required to ask participants whether AE's occurred as a
result of performing the walking intervention.
A strength of the present study was the utilization of the
centralized patient record systems of the VA medical sys-
tem to link physicians, dietitians, and behavioral research-
ers. This centralized medical record system allowed us to
closely track adverse medical events that occur to partici-
pants during the study. Close tracking of adverse medical
events also allowed us to get suspended participants back
in the walking program quickly after medical issues were
resolved. Second, rather than recruiting asymptomatic or
healthy participants, the study deliberately recruited high-
risk individuals from regions across the U.S. to enhance
external validity and to test the effectiveness of this
approach in various primary care settings across the U.S.
Third, extensive pre-activity screening was viewed as
redundant since these participants were already under the
care of a physician aware of salient health risks. Our inclu-
sion criteria required that participants be under physician
care during intervention participation so that the physi-
cian would not only provide one-time medical clearance
at baseline, but also be available for helping the partici-
pant overcome transient medical problems that might
affect compliance with the six-month intervention. As our
present findings show, older and chronically ill adults
commonly experience medical events of varying severity
that may be barriers to PA participation. Our study sup-
ports previous assertions that primary care physicians can
play a vital role in promoting safe exercise participation in
patients performing unsupervised activity [44].
Our findings must be viewed within the limitations of the
study design. The absence of a non-active control group
limits the comparison between AE's that occurred in a
comparable group of sedentary individuals versus the
walkers in Veterans Walk for Health. Also, while primary
care practices may be an ideal setting to help adults at risk
for chronic disease initiate a lifestyle PA program, many
providers lack the integrated reporting system developed
by the VA and used in the current study to monitor
patients. Many hospital systems lack the electronic and
centralized patient record system, which permits medical
personnel to review a patient's comprehensive medicalPage 10 of 12
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changes in medications, fitness, or disability. Although
the present study appears to provide support for the
premise that lifestyle PA interventions can be safely imple-
mented among older and at-risk adults, our findings also
underline the need for primary care access to overcome
the inevitable medical events associated with an aging and
increasingly high-risk population.
Conclusion
Little is known about the risk for adverse events among
high-risk individuals in response to unsupervised lifestyle
activity programs that emphasize moderate intensity PA
like walking. This study addressed this gap in the literature
by targeting a population that, despite high risk for
chronic disease morbidity, could benefit from a simple PA
intervention. We found that individuals at high risk for
CVD could safely start an unsupervised home-based walk-
ing program with a low risk for adverse reactions to walk-
ing. However, we documented that 87% of our reported
adverse events were due to medical events unrelated to
walking but likely to occur among an older, diseased pop-
ulation. Helping individuals resume PA after a medical
problem is challenging, but we believe it should be a pri-
ority. Recognizing that exercise interventionists can inter-
face with primary care professionals to help chronically
diseased individuals overcome these medical barri-
ers,[15,20,44] we described our safety protocols as one
approach to address this unmet health service need. There
is increasing appreciation that safety screening of PA pro-
gram participation is an ongoing process [20]. An essen-
tial and overlooked role of this process is not only to
document medical problems associated with PA partici-
pation, but also to facilitate solutions that help individu-
als cope with the health barriers to PA program adherence
and thus, avoid the deleterious effects of inactivity. Fur-
ther research is needed to assess the risk of adverse events
in community-based PA interventions in high-risk popu-
lations and to document methods of helping individuals
overcome transient health problems to resume the level of
PA necessary to confer health protective benefits.
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